Dive Into Dollar Tr...
Health Care: Drugs
Optimer Pharmaceuticals Inc. (OPTR: NASDAQ)
$14.70 -0.27 | -1.80%
05/20/13 - 03:06 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 420,700 | 66,000 | 66,000 | 11,000 | 7,000 | 7,000 | 32,000 |
| Shares Bought | 568,700 | 66,000 | 66,000 | 11,000 | 7,000 | 7,000 | 35,461 |
| Shares Sold | 148,000 | 0 | 0 | 0 | 0 | 0 | 3,461 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 44.36M | 48.39M | 43.41M | 44.19M | 43.49M | 44.03M | 43.70M |
| Shares Bought | 13.04M | 17.37M | 11.96M | 12.08M | 4.10M | 3.92M | 3.80M |
| Shares Sold | 9.52M | 8.47M | 13.45M | 13.43M | 10.81M | 9.76M | 10.05M |
Portfolios with OPTR
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
Latest OPTR Headlines from TheStreet
- 3 Biotech Stocks Rising on Big Volume 02.27.13 | 02:02 pm
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- 5 Biotech Stocks Rising on Unusual Volume 11.20.12 | 02:11 pm
- 5 Stocks Moving Higher on Big Volume 09.04.12 | 02:09 pm
- Optimer Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript 07.31.12 | 10:07 pm
- Optimer Pharmaceuticals Inc. Stock Downgraded (OPTR) 05.17.12 | 05:05 am
- 5 Earnings Stocks Poised to Pop 05.09.12 | 10:05 am
- 7 Stocks Spiking on Unusual Volume 04.25.12 | 01:04 pm
- Optimer Pharmaceuticals Inc. Stock Upgraded (OPTR) 03.09.12 | 04:03 am
- Optimer Pharmaceuticals Inc. (OPTR): Today's Featured Health Care Winner 11.23.11 | 04:11 pm
Press Releases for OPTR
- Optimer Pharmaceuticals Appoints Eric Sirota As Chief Operating Officer - PR Newswire 05.13.13 | 04:05 pm
- Optimer Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results - PR Newswire 05.02.13 | 08:05 am
- DIFICID® (fidaxomicin) Tablets Approved In Australia - PR Newswire 04.26.13 | 08:04 am
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 03.15.13 | 08:03 am
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 02.27.13 | 08:02 am
- Optimer Pharmaceuticals' Board Of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer - PR Newswire 02.27.13 | 08:02 am
- New Analysis Shows Age Has A Significant Effect On Outcomes In Patients Being Treated For Clostridium Difficile Infection (CDI) - PR Newswire 02.14.13 | 08:02 am
- Optimer Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year 2012 Financial Results - PR Newswire 02.07.13 | 08:02 am
- Optimer Pharmaceuticals To Present At Leerink Swann Global Healthcare Conference - PR Newswire 02.07.13 | 08:02 am
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 02.01.13 | 08:02 am
Partner Headlines for OPTR
- Narrower Loss at Optimer - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Pipeline Progress at Cubist Pharma - Analyst Blog - Zacks 11.01.12 | 06:11 pm
- Earnings Preview: Cubist Pharma - Analyst Blog - Zacks 10.17.12 | 09:10 am
- Optimer Pharma to Sell Optimer Bio Stake - Analyst Blog - Zacks 10.09.12 | 07:10 pm
- UPDATE: Oppenheimer Downgrades Optimer Pharmaceuticals to Perform on Near-Term Outlook - Benzinga 10.09.12 | 01:10 pm
- UPDATE: Morgan Stanley Initiates Optimer Pharmaceuticals at Underweight on Risk/Reward - Benzinga 10.04.12 | 01:10 pm
- How one bull is playing Optimer Pharma - NASDAQ 09.11.12 | 09:09 am
- Optimer's Dificid OK'd in Canada - Analyst Blog - Zacks 07.09.12 | 07:07 pm
- Optimer Earns Milestone Payment - Analyst Blog - Zacks 06.08.12 | 04:06 pm
- UPDATE: Ladenburg Thalmann Maintains Buy Rating, Raises PT for Optimer Pharmaceuticals - Benzinga 05.11.12 | 09:05 am
